J.W. Cole Advisors’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.39M | Buy |
22,234
+14,203
| +177% | +$1.53M | 0.05% | 355 |
|
|
2025
Q1 | $810K | Buy |
8,031
+3,032
| +61% | +$306K | 0.03% | 601 |
|
|
2024
Q4 | $447K | Buy |
4,999
+985
| +25% | +$88K | 0.02% | 637 |
|
|
2024
Q3 | $336K | Buy |
4,014
+25
| +0.6% | +$2.1K | 0.01% | 739 |
|
|
2024
Q2 | $307K | Buy |
3,989
+336
| +9% | +$25.9K | 0.01% | 695 |
|
|
2024
Q1 | $250K | Buy |
+3,653
| New | +$250K | 0.01% | 756 |
|
|
2020
Q4 | – | Sell |
-10,265
| Closed | -$392K | – | 664 |
|
|
2020
Q3 | $392K | Buy |
+10,265
| New | +$392K | 0.03% | 475 |
|